Biotech and life sciences occupiers in Cape Town typically cluster in Century City, plan ~320 sqft per seat at high-end fit-out ($7100–10500/sqft), and pay around 180 ZAR/sqft ($11 USD) on Class A.
Biotech and life sciences occupiers in Cape Town typically cluster in Century City, plan ~320 sqft per seat at high-end fit-out">fit-out ($7100–10500/sqft), and pay around 180 ZAR/sqft ($11 USD) on Class A.
Biotech and life sciences occupiers in Cape Town typically anchor in Century City. Insurance, banking, tech, professional services.
Class A rent in Cape Town runs 180 ZAR/sqft ($11 USD) on a 5-year lease with 5 months free. Prime submarkets sit at or modestly above the city index.
Typical biotech and life sciences fit-out targets high-end specification at $7100–10500/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 320 sqft per seat blended (workstation + circulation + amenity). A 100-headcount biotech office in Cape Town typically targets 32,000 sqft of leasable area.
Cluster effects are decisive: PhD-grade talent concentrates near academic-medical anchors and translational research institutes. Deep tech, hospitality, BPO, and creative talent. Strong English-language professional base. Strong feed from UCT, Stellenbosch, and CPUT. Cape Town has structurally attracted in-migration from Johannesburg and abroad.
Headline corporate tax: 27%. Net leases. 5-7 year terms with escalation clauses. Free rent of 3-7 months and TI of ZAR 800-1,500/sqm typical.
| city | Cape Town |
|---|---|
| industry | Biotech and life sciences |
| naics | 541714, 541715, 325412 |
| preferredSubmarket | Century City |
| preferredFitoutSpec | High-end |
| fitoutBand | $7100–10500/sqft |
| sqftPerSeat | 320 |
| classARentLocal | 180 ZAR/sqft/yr |
| classARentUsd | $11/sqft/yr |
| vacancyPct | 12.4% |
| typicalLeaseYears | 5 |
| typicalRentFreeMonths | 5 |
| talentIndex | 78 |
| corporateTaxPct | 27% |
Reviewed by Samuel Okafor — EMEA contributing editor. Last updated 2026-04-15. See our methodology and editorial standards.